Movelat Relief (Mucopolysaccharide Polysulfuric Acid Ester, Salicylic Acid)

Mucopolysaccharide Polysulfuric Acid Ester, the active ingredient in Movelat Relief, is a dermatological agent presented as a topical formulation for cutaneous use. Combined with salicylic acid, it helps to soften keratin, promote desquamation, and reduce mild skin irritation in adult patients with conditions such as callus, corn, and seborrheic dermatitis.

GNH USA supplies Movelat Relief as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for cross‑border distribution.

Movelat Relief, a topical dermatological preparation containing a keratolytic and anti‑inflammatory combination, is used for several skin surface conditions. - Acne vulgaris: reduces comedone formation and promotes clearance of inflammatory lesions. - Callus and corn: softens hyperkeratotic tissue to facilitate gentle removal. - Psoriasis plaques: helps to decrease scaling and redness on mild to moderate plaques. - Seborrheic dermatitis: alleviates flaking and erythema on scalp and face. - Warts (verruca vulgaris): assists in gradual keratin breakdown to reduce lesion size.

Common Side Effects: - Skin irritation: mild redness or discomfort at the application site. - Dryness: increased transepidermal water loss leading to flaky skin. - Peeling: accelerated desquamation causing visible skin shedding. - Itching: transient pruritus during early treatment. - Burning sensation: brief warmth upon application. - Erythema: localized redness.

Serious or Rare Side Effects: - Allergic contact dermatitis: severe rash, swelling, or blistering. - Extensive skin ulceration: deep tissue damage in over‑treated areas. - Systemic salicylate toxicity: rare, may present with tinnitus or nausea if large amounts are absorbed. - Photosensitivity: heightened reaction to sunlight. - Secondary infection: bacterial overgrowth in compromised skin. - Hyperpigmentation: persistent darkening of treated skin.

Before using Movelat Relief, consider the following precautions: - Pregnancy: consult a healthcare professional before application. - Breastfeeding: use only if advised by a physician. - Age restriction: not recommended for children under 12 years. - Application area: avoid eyes, mucous membranes, and broken skin. - Concurrent skin disease: do not apply on infected or inflamed lesions. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Movelat Relief may interact with other topical or systemic agents. Monitor for combined effects.

Major Interactions (Avoid): - Systemic salicylates: concurrent use may increase risk of salicylate toxicity. - Other keratolytics (e.g., urea, lactic acid): may cause excessive irritation.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may alter drug absorption and increase irritation. - Retinoids: combined use can heighten skin sensitivity. - Phototherapy: may increase photosensitivity risk. - Antifungal creams: potential for reduced efficacy of either product.